Literature DB >> 12663452

Gene expression profiling of plasma cells and plasmablasts: toward a better understanding of the late stages of B-cell differentiation.

Karin Tarte1, Fenghuang Zhan, John De Vos, Bernard Klein, John Shaughnessy.   

Abstract

Plasma cells (PCs), the end point of B-cell differentiation, are a heterogeneous cell compartment comprising several cell subsets from short-lived highly proliferative plasmablasts to long-lived nondividing fully mature PCs. Whereas the major transcription factors driving the differentiation of B cells to PCs were recently identified, the subtle genetic changes that underlie the transition from plasmablasts to mature PCs are poorly understood. We recently described an in vitro model making it possible to obtain a large number of cells with the morphologic, phenotypic, and functional characteristics of normal polyclonal plasmablastic cells (PPCs). Using Affymetrix microarrays we compared the gene expression profiles of these PPCs with those of mature PCs isolated from tonsils (TPCs) and bone marrow (BMPCs), and with those of B cells purified from peripheral blood (PBB cells) and tonsils (TBCs). Unsupervised principal component analysis clearly distinguished the 5 cell populations on the basis of their differentiation and proliferation status. Detailed statistical analysis allowed the identification of 85 PC genes and 40 B-cell genes, overexpressed, respectively, in the 3 PC subsets or in the 2 B-cell subsets. In addition, several signaling molecules and antiapoptotic proteins were found to be induced in BMPCs compared with PPCs and could be involved in the accumulation and prolonged survival of BMPCs in close contact with specialized stromal microenvironment. These data should help to better understand the molecular events that regulate commitment to a PC fate, mediate PC maintenance in survival niches, and could facilitate PC immortalization in plasma cell dyscrasias.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12663452     DOI: 10.1182/blood-2002-10-3161

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  80 in total

1.  Site-specific expression of polycomb-group genes encoding the HPC-HPH/PRC1 complex in clinically defined primary nodal and cutaneous large B-cell lymphomas.

Authors:  Frank M Raaphorst; Maarten Vermeer; Elly Fieret; Tjasso Blokzijl; Danny Dukers; Richard G A B Sewalt; Arie P Otte; Rein Willemze; Chris J L M Meijer
Journal:  Am J Pathol       Date:  2004-02       Impact factor: 4.307

2.  Early preplasma cells define a tolerance checkpoint for autoreactive B cells.

Authors:  Donna A Culton; Brian P O'Conner; Kara L Conway; Ramiro Diz; Jennifer Rutan; Barbara J Vilen; Stephen H Clarke
Journal:  J Immunol       Date:  2006-01-15       Impact factor: 5.422

3.  The molecular classification of multiple myeloma.

Authors:  Fenghuang Zhan; Yongsheng Huang; Simona Colla; James P Stewart; Ichiro Hanamura; Sushil Gupta; Joshua Epstein; Shmuel Yaccoby; Jeffrey Sawyer; Bart Burington; Elias Anaissie; Klaus Hollmig; Mauricio Pineda-Roman; Guido Tricot; Frits van Rhee; Ronald Walker; Maurizio Zangari; John Crowley; Bart Barlogie; John D Shaughnessy
Journal:  Blood       Date:  2006-05-25       Impact factor: 22.113

Review 4.  Microarray-based understanding of normal and malignant plasma cells.

Authors:  John De Vos; Dirk Hose; Thierry Rème; Karin Tarte; Jérôme Moreaux; Karéne Mahtouk; Michel Jourdan; Hartmut Goldschmidt; Jean-François Rossi; Friedrich W Cremer; Bernard Klein
Journal:  Immunol Rev       Date:  2006-04       Impact factor: 12.988

5.  Sustained secretion of immunoglobulin by long-lived human tonsil plasma cells.

Authors:  Jacob M van Laar; Marc Melchers; Y K Onno Teng; Boris van der Zouwen; Rozbeh Mohammadi; Randy Fischer; Leonid Margolis; Wendy Fitzgerald; Jean-Charles Grivel; Ferdinand C Breedveld; Peter E Lipsky; Amrie C Grammer
Journal:  Am J Pathol       Date:  2007-08-09       Impact factor: 4.307

6.  An evolutionarily conserved program of B-cell development and activation in zebrafish.

Authors:  Dawne M Page; Valerie Wittamer; Julien Y Bertrand; Kanako L Lewis; David N Pratt; Noemi Delgado; Sarah E Schale; Caitlyn McGue; Bradley H Jacobsen; Alyssa Doty; Yvonne Pao; Hongbo Yang; Neil C Chi; Brad G Magor; David Traver
Journal:  Blood       Date:  2013-07-16       Impact factor: 22.113

7.  Beyond Autoantibodies: Biologic Roles of Human Autoreactive B Cells in Rheumatoid Arthritis Revealed by RNA-Sequencing.

Authors:  Ankit Mahendra; Xingyu Yang; Shaza Abnouf; Jay R T Adolacion; Daechan Park; Sanam Soomro; Jason Roszik; Cristian Coarfa; Gabrielle Romain; Keith Wanzeck; S Louis Bridges; Amita Aggarwal; Peng Qiu; Sandeep K Agarwal; Chandra Mohan; Navin Varadarajan
Journal:  Arthritis Rheumatol       Date:  2019-02-23       Impact factor: 10.995

8.  Gene expression analysis of plasmablastic lymphoma identifies downregulation of B-cell receptor signaling and additional unique transcriptional programs.

Authors:  J Chapman; A J Gentles; V Sujoy; F Vega; C I Dumur; T L Blevins; L Bernal-Mizrachi; M Mosunjac; A Pimentel; D Zhu; I S Lossos
Journal:  Leukemia       Date:  2015-04-24       Impact factor: 11.528

9.  The Bcl-2 family member Bfl-1/A1 is strongly repressed in normal and malignant plasma cells but is a potent anti-apoptotic factor for myeloma cells.

Authors:  Karin Tarte; Michel Jourdan; Jean Luc Veyrune; Ingolf Berberich; Geneviève Fiol; Nicole Redal; John Shaughnessy; Bernard Klein
Journal:  Br J Haematol       Date:  2004-05       Impact factor: 6.998

10.  The effects of probiotic supplementation on the gene expressions of immune cell surface markers and levels of antibodies and pro-inflammatory cytokines in human milk.

Authors:  Veronique Demers-Mathieu; Gabrielle B Mathijssen; Ciera DaPra; Elena Medo
Journal:  J Perinatol       Date:  2020-11-18       Impact factor: 2.521

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.